NEW YORK — Chinese single-cell genomics firm Analytical Biosciences (ABio) said on Monday that it has partnered with BioMap to develop commercial analytical and artificial intelligence-based computing platforms for single-cell genomics.
The deal includes an undisclosed strategic investment from BioMap, an AI-powered life sciences company founded by Baidu executives. Additional terms were not disclosed.